Home » Newsletters » BioWorld

BioWorld

April 28, 1992

View Archived Issues

MCLAUCHLAN SUCCEEDS SCHEIN AS UBS PRESIDENT

START-UP TO USE DISEASED CELLS TO LOCATE DRUGS

EPITOPE MOVES ON EPIBLOT, ORASURE

CYTEL GRANT FOR CHRONIC HEPATITIS VACCINE

BRITISH-BIO FILES SILENT IPO

IMPENDING FDA-CENTOCOR DEAL REPORTED

IMNX MOVES UP ON $900 MILLION VALUATION

CYGNUS NICOTINE PATCH APPROVED FOR MARKET